Donor Lymphocyte Infusion in Hematologic Malignancies—Good to be Fresh?-Reference-Cited by-同舟云学术

Donor Lymphocyte Infusion in Hematologic Malignancies—Good to be Fresh?

Published:2016-02 Issue:2 Volume:16 Page:111-115
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Hossain Nasheed Mohammad,Klumpp Thomas,Ulicny John,Garner Michael,Kropf Patricia Lamont,Mangan Kenneth F.,Barta Stefan Klaus,Fung Henry C.,Martin Mary Ellen

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference7 articles.

1. Donor lymphocyte infusion therapy;Roush;Transfus Med Rev,2002

2. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplantation patients;Kolb;Blood,1990

3. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation;Collins;J Clin Oncol,1997

4. Donor lymphocyte infusions for acute myeloid leukaemia;Soiffer;Best Pract Res Clin Haematol,2008

5. G-CSF mobilized vs conventional donor lymphocytes for therapy of relapse or incomplete engraftment after allogeneic hematopoietic transplantation;Abbi;Bone Marrow Transplant,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Mixed Chimerism After Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Major;American Journal of Pediatrics;2024-02-20

2. Can GCSF-stimulated donor lymphocyte infusions improve outcomes for relapsed disease following allogeneic hematopoietic cell transplantation? A systematic review and meta-analysis;Leukemia & Lymphoma;2022-09-13

3. A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment;Journal of Clinical Medicine;2020-07-12

4. Injections de lymphocytes du donneur (DLI) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC);Bulletin du Cancer;2019-01

5. Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program;Biology of Blood and Marrow Transplantation;2017-06